Lilly & Co. (LLY) Declares $0.49 Quarterly Dividend; 3.1% Yield

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. AMZN
2. INTC
3. COIN
4. PINS
5. FSLR
6. RDDT
7. SBUX
8. SNDK
9. FND
10. RBLX

Go back to Lilly & Co. (LLY) Declares $0.49 Quarterly Dividend; 3.1% Yield

Lilly & Co. (LLY) Reports FDA Acceptance of Empagliflozin + Metformin NDA

October 21, 2014 8:33 AM EDT

The U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination, an investigational compound being studied for the treatment of adults with type 2 diabetes (T2D). Empagliflozin plus metformin is part of the Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) Diabetes alliance portfolio.

"Type 2 diabetes... More